This is archived HHS content.
Skip to main content
HHS
.gov
Search
U.S. Department of Health & Human Services
Search
Close
A-Z Index
About HHS
Programs & Services
Grants & Contracts
Laws & Regulations
Home
>
Blog
> Authors > Rick Bright, Ph. D.
Text Resize
A
A
A
Print
Share
Categories
Coronavirus (9)
Drug Pricing (12)
Emergency Preparedness and Response (11)
Fraud (2)
Global Health (11)
Grants and Contracts (4)
Health Data (2)
Health Insurance Reform (4)
Health IT (6)
HHS Administrative (29)
Holidays and Observances (19)
Medicare and Medicaid (1)
Mental Health and Substance Abuse (9)
Opioids (17)
Prevention and Wellness (42)
Programs for Families and Children (30)
Public Health and Safety (37)
Research (20)
Telehealth (1)
Value-Based Care (2)
Author: Rick Bright, Ph. D.
A Newly FDA-Licensed Vaccine for the Prevention of Smallpox and Monkeypox Marks a Major Milestone in Domestic and Global Health Security
September 24, 2019
By:
Rick Bright, Ph. D.
, Deputy Assistant Secretary for Preparedness and Response and Director, Biomedical Advanced Research and Development Authority (BARDA)
Posted In:
Emergency Preparedness and Response
|
Global Health
Tagged:
smallpox
Sign Up For Blog Updates
Enter your email:
Subscribe to RSS
Receive latest updates
Back to
T
op
This is archived HHS content.